Explantation of implantable defibrillator leads using open heart surgery or percutaneous techniques

被引:23
作者
Camboni, Daniele
Wollmann, Christian G.
Loeher, Andreas
Gradaus, Rainer
Scheld, Hans Heinrich
Schmid, Christof
机构
[1] Univ Hosp, Dept Thorac & Cardiovasc Surg, Munster, Germany
[2] Univ Hosp, Dept Cardiol & Angiol, Munster, Germany
关键词
D O I
10.1016/j.athoracsur.2007.03.048
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. To remove failing or infected implantable cardioverter defibrillator leads, percutaneous techniques and open heart surgery are two common approaches. However, well-defined indications for either technique are not available. We summarize our experience with implantable cardioverter defibrillator system explantation using open heart surgery and percutaneous lead removal. Methods. A total of 1,391 transvenously introduced implantable cardioverter defibrillator systems were implanted during the analyzed time interval from January 1995 to June 2005 in our institution. In 21 patients (1.5%), open heart surgery for implantable cardioverter defibrillator lead and generator explantation was applied (group A), and in 53 patients (3.8%), a percutaneous lead removal was possible (group B). The log-rank test was used to calculate differences in survival between both patient groups, and the Student's t test was applied for differences in nonlethal complications. Results. The 30-day, 6-month, 12-month, and 5-year survival rates were 91%, 91%, 81%, and 71%, respectively, for group A patients, and 100%, 100%, 94%, and 78%, respectively, for group B patients, which was not statistically different (p = 0.11). After open heart surgery, survival was comparable for cases with lead removal because of lead infection and those with lead malfunction (p = 0.28); however, patients with open heart surgery had a longer hospital stay (p = 0.03). Student's t test revealed no statistical difference in nonlethal complications between both patient groups (p = 0.37). Conclusions. As open heart surgery yielded similar results with regard to survival and complications, implantable cardioverter defibrillator lead removal using extracorporeal circulation may be well justified as a last therapeutic option, eg, in case of large bacterial vegetations.
引用
收藏
页码:50 / 55
页数:6
相关论文
共 16 条
[1]  
BLOCK M, 1991, Z KARDIOL, V80, P657
[2]  
BRODMANN R, 1992, J THORAC CARDIOVASC, V103, P1164
[3]   Pacemaker infective endocarditis [J].
Cacoub, P ;
Leprince, P ;
Nataf, P ;
Hausfater, P ;
Dorent, R ;
Wechsler, B ;
Bors, V ;
Pavie, A ;
Piette, JC ;
Gandjbakhch, I .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (04) :480-484
[4]   Gross and microscopic pathological changes associated with nonthoracotomy implantable defibrillator leads [J].
Epstein, AE ;
Kay, GN ;
Plumb, VJ ;
Dailey, SM ;
Anderson, PG .
CIRCULATION, 1998, 98 (15) :1517-1524
[5]   Initial experience with larger laser sheaths for the removal of transvenous pacemaker and implantable defibrillator leads [J].
Epstein, LM ;
Byrd, CL ;
Wilkoff, BL ;
Love, CJ ;
Sellers, TD ;
Hayes, DL ;
Reiser, C .
CIRCULATION, 1999, 100 (05) :516-525
[6]  
Hemmer W, 2002, Z KARDIOL, V91, P956, DOI 10.1007/s00392-002-0891-2
[7]   Removal of endocardial defibrillation leads [J].
Jordaens, L ;
VanBelleghem, Y ;
Herregods, L .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1996, 19 (01) :127-129
[8]   Systemic infection related to endocarditis on pacemaker leads - Clinical presentation and management [J].
Klug, D ;
Lacroix, D ;
Savoye, C ;
Goullard, L ;
Grandmougin, D ;
Hennequin, JL ;
Kacet, S ;
Lekieffre, J .
CIRCULATION, 1997, 95 (08) :2098-2107
[9]  
Love CJ, 2000, PACE, V23, P544
[10]   Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia [J].
Moss, AJ ;
Hall, WJ ;
Cannom, DS ;
Daubert, JP ;
Higgins, SL ;
Klein, H ;
Levine, JH ;
Saksena, S ;
Waldo, AL ;
Wilber, D ;
Brown, MW ;
Heo, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (26) :1933-1940